S. B. Baylin and J. G. Herman, DNA hypermethylation in tumorigenesis: epigenetics joins genetics, Trends in Genetics, vol.16, issue.4, pp.168-174, 2000.
DOI : 10.1016/S0168-9525(99)01971-X

A. B. Benson, Epidemiology, disease Progression, and Economic Burden of Colorectal Cancer, Journal of Managed Care Pharmacy, vol.13, issue.6 Supp C, pp.5-18, 2007.
DOI : 10.18553/jmcp.2007.13.s6-c.5

G. Bindea, B. Mlecnik, M. Tosolini, A. Kirilovsky, M. Waldner et al., Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer, Immunity, vol.39, issue.4, pp.782-95, 2013.
DOI : 10.1016/j.immuni.2013.10.003

C. Blank, T. F. Gajewski, and A. Mackensen, Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy, Cancer Immunology, Immunotherapy, vol.173, issue.Suppl 7, 2005.
DOI : 10.4049/jimmunol.173.2.945

C. R. Boland, S. N. Thibodeau, S. R. Hamilton, D. Sidransky, J. R. Eshleman et al., « A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer, Cancer Research, vol.58, issue.22, pp.5248-57, 1998.

T. Boon, P. Et, J. Van-der-bruggen-brahmer, K. L. Reckamp, P. Baas et al., Human tumor antigens recognized by T lymphocytes, Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer, pp.725-754, 1996.
DOI : 10.1084/jem.183.3.725

URL : http://jem.rupress.org/content/jem/183/3/725.full.pdf

F. Bray, E. Jian-song-ren, J. Masuyer, and . Ferlay, « Global Estimates of Cancer Prevalence for 27 Sites in the Adult Population, International Journal of Cancer, vol.132, issue.5, 2008.

F. M. Burnet, The Concept of Immunological Surveillance, Progress in Experimental Tumor Research, pp.1-27, 1970.
DOI : 10.1159/000386035

D. V. Catenacci, M. Kozloff, H. L. Kindler, and . Et-blase-polite, « Personalized Colon Cancer Care, Seminars in Oncology, vol.38, issue.2, 2010.

. Dong, W. Zhong-yi, X. Zhong, J. Zhang, Z. Su et al., « Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma ». Clinical Cancer Research, An Official Journal of the American Association for Cancer Research, vol.23, issue.12, 2017.

G. P. Dunn, T. Allen, H. Bruce, L. J. Ikeda, R. D. Old et al., Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.3, issue.11, pp.10-1038, 2002.
DOI : 10.1038/ni1102-991

M. Dhodapkar, M. Geller, and D. Chang, A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma, The Journal of Experimental Medicine, vol.81, issue.12, pp.1667-76, 2003.
DOI : 10.1182/blood.V97.7.2067

G. P. Dunn, J. Lloyd, R. D. Old, and . Schreiber, The Immunobiology of Cancer Immunosurveillance and Immunoediting, Immunity, vol.21, issue.2, pp.137-148, 2004.
DOI : 10.1016/j.immuni.2004.07.017

C. Elie and I. Colombet, « Methods of evaluation of reproducibility ». Sang thrombose vaisseaux---Sang Thrombose Vaisseaux, pp.138-145, 2011.

P. Ehrlich, Ueber den jetzigen Stand der Karzinomforschung, Ned. Tijdschr. Geneeskd, vol.5, pp.273-290, 1909.

J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-386, 2015.
DOI : 10.1016/S1470-2045(12)70137-7

URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.29210/pdf

J. Folkman, P. Hahnfeldt, and E. L. Hlatky, « Cancer: Looking Outside the Genome », Nature Reviews. Molecular Cell Biology, vol.1, issue.1, 2000.

W. Fridman, F. Herman, and . Pagès, Catherine Sautès-Fridman, et Jérôme Galon. 2012. « The Immune Contexture in Human Tumours: Impact on Clinical Outcome », Nature Reviews. Cancer, vol.12, issue.4

D. I. Gabrilovich and S. Nagaraj, Myeloid-derived suppressor cells as regulators of the immune system, Nature Reviews Immunology, vol.172, issue.3, 2009.
DOI : 10.4049/jimmunol.172.7.4418

J. Galon, A. Costes, F. Sanchez-cabo, A. Kirilovsky, B. Mlecnik et al., Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, p.313, 2006.
DOI : 10.1126/science.1129139

J. Galon, F. Pagès, F. M. Marincola, H. K. Angell, M. Thurin et al., Cancer classification using the Immunoscore: a worldwide task force, Journal of Translational Medicine, vol.10, issue.1, pp.205-215, 2012.
DOI : 10.1186/1479-5876-10-1

URL : https://hal.archives-ouvertes.fr/inserm-00780742

J. Galon, F. Pagès, F. M. Marincola, M. Thurin, G. Trinchieri et al., The immune score as a new possible approach for the classification of cancer, Journal of Translational Medicine, vol.10, issue.1, 2012.
DOI : 10.1186/1479-5876-9-32

URL : https://hal.archives-ouvertes.fr/inserm-00664981

B. Gaugler, B. Van-den-eynde, P. Van-der-bruggen, P. Romero, J. J. Gaforio et al., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, Human Gene MAGE-3 Codes for an Antigen Recognized on a Melanoma by Autologous Cytolytic T Lymphocytes, pp.921-951, 1994.
DOI : 10.1084/jem.179.3.921

M. Gerling, V. J. Nikè, L. M. Büller, S. Kirn, O. Joost et al., Erratum: Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth, Nature Communications, vol.7, 2016.
DOI : 10.1038/ncomms12936

F. Grillo, S. Pigozzi, P. Ceriolo, P. Calamaro, R. Fiocca et al., Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections, Histochemistry and Cell Biology, vol.59, issue.1, pp.93-99, 2015.
DOI : 10.1369/0022155411398488

A. Habr-gama, R. O. Perez, W. Nadalin, J. Sabbaga, U. Ribeiro et al., Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy, Transactions of the ... Meeting of the American Surgical Association, vol.CXXII, issue.&NA;, pp.711-717, 2004.
DOI : 10.1097/01.sla.0000141194.27992.32

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356472/pdf

D. Hanahan and R. A. Weinberg, « The hallmarks of cancer, pp.57-70, 2000.

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, 2011.
DOI : 10.1016/j.cell.2011.02.013

F. Hodi, S. J. Stephen, D. F. Day, R. W. Mcdermott, J. A. Weber et al., Improved Survival with Ipilimumab in Patients with Metastatic Melanoma, New England Journal of Medicine, vol.363, issue.8, pp.711-734, 2010.
DOI : 10.1056/NEJMoa1003466

C. Hollenbeak, M. Todd, E. Billingsley, G. Harper, A. Dyer et al., Increased incidence of melanoma in renal transplantation recipients, Cancer, vol.107, issue.9, pp.1962-1969, 2005.
DOI : 10.1093/jnci/94.20.1537

V. Hofman, M. Ilie, E. Long, C. Butori, S. Lassalle et al., « [Issues and current limits for immunohistochemical assessment of PD-L1 status in bronchial biopsies] », Bulletin Du Cancer, vol.103, issue.4, 2016.

D. Huang and X. Du, Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination, World Journal of Gastroenterology, vol.14, issue.12, pp.1823-1850, 2008.
DOI : 10.3748/wjg.14.1823

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700405/pdf

J. R. Jass, Lymphocytic infiltration and survival in rectal cancer., Lymphocytic Infiltration and Survival in Rectal Cancer, pp.585-89, 1986.
DOI : 10.1136/jcp.39.6.585

URL : http://jcp.bmj.com/content/jclinpath/39/6/585.full.pdf

S. Jothy, S. Y. Yuan, and E. K. Shirota, « Transcription of Carcinoembryonic Antigen in Normal Colon and Colon Carcinoma, Situ Hybridization Study and Implication for a New in Vivo Functional Model, pp.250-57, 1993.

J. B. Katz, A. J. Muller, and G. C. Prendergast, Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape, Immunological Reviews, vol.176, issue.1, 2008.
DOI : 10.1093/carcin/16.2.399

H. Kawakami, Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer, Clin Gastroenterol Hepatol, vol.14, issue.5, pp.651-658, 2016.

M. Kebenko, A. Drenckhan, S. J. Gros, M. Jücker, N. Grabinski et al., ErbB2 signaling activates the Hedgehog pathway via PI3K???Akt in human esophageal adenocarcinoma: Identification of novel targets for concerted therapy concepts, Cellular Signalling, vol.27, issue.2, 2015.
DOI : 10.1016/j.cellsig.2014.11.022

S. Kim, H. J. Hee, D. Y. Chang, J. W. Kim, J. Y. Park et al., What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?, Cancer Research and Treatment, vol.48, issue.3, 2016.
DOI : 10.4143/crt.2015.254

N. Kobayashi, Malignant neoplasms in registered cases of primary immunodefi ciency syndrome, Jpn J Clin Oncol, vol.15, pp.307-319, 1985.

C. M. Koebel, W. Vermi, J. B. Swann, N. Zerafa, S. J. Rodig et al., Adaptive immunity maintains occult cancer in an equilibrium state, Nature, vol.410, issue.7171, pp.903-910, 2007.
DOI : 10.4049/jimmunol.169.7.3667

A. Laurinaviciene, B. Plancoulaine, I. Baltrusaityte, R. Meskauskas, J. Besusparis et al., Yasir Iqbal, Paulette Herlin, et Arvydas Laurinavicius, Digital Immunohistochemistry Platform for the Staining Variation Monitoring Based on Integration of Image and Statistical Analyses with Laboratory Information System ». Diagnostic Pathology 9, 2014.

D. T. Le, N. Jennifer, H. Uram, B. R. Wang, H. Bartlett et al., PD-1 Blockade in Tumors with Mismatch-Repair Deficiency, PD-1 Blockade in Tumors with Mismatch-Repair Deficiency, pp.2509-2529, 2015.
DOI : 10.1056/NEJMoa1500596

A. Lièvre, J. Bachet, D. L. Corre, V. Boige, B. Landi et al., Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer, Cancer Research, vol.66, issue.8, pp.3992-95, 2006.
DOI : 10.1158/0008-5472.CAN-06-0191

L. A. Loeb, « Mutator Phenotype May Be Required for Multistage Carcinogenesis », Cancer Research, vol.51, issue.12, pp.3075-79, 1991.

L. A. Loeb, R. Keith, J. P. Loeb, and . Anderson, Multiple mutations and cancer, Proceedings of the National Academy of Sciences, vol.182, issue.23, 2003.
DOI : 10.1128/JB.182.23.6742-6750.2000

F. Loupakis, C. Cremolini, L. Salvatore, G. Masi, E. Sensi et al., FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer, European Journal of Cancer, vol.50, issue.1, 1990.
DOI : 10.1016/j.ejca.2013.08.024

A. D. Luster, P. Et, and . Leder, IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo, Journal of Experimental Medicine, vol.178, issue.3, pp.1057-65, 1993.
DOI : 10.1084/jem.178.3.1057

L. R. Meyer, The Eighth Edition AJCC Cancer Staging Manual, pp.978-981, 2017.

B. Mlecnik, M. Tosolini, A. Kirilovsky, A. Berger, G. Bindea et al., Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction, Journal of Clinical Oncology, vol.29, issue.6, 2011.
DOI : 10.1200/JCO.2010.30.5425

F. Moinfar, Y. Gao-man, L. Arnould, G. L. Bratthauer, M. Ratschek et al., « Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis », Cancer research, vol.60, issue.9, pp.2562-2566, 2000.

S. Ogino and A. Goel, Molecular Classification and Correlates in Colorectal Cancer, The Journal of Molecular Diagnostics, vol.10, issue.1, 2008.
DOI : 10.2353/jmoldx.2008.070082

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175539/pdf

L. J. Old, E. A. Et, and . Boyse, Immunology of Experimental Tumors, Annual Review of Medicine, vol.15, issue.1, 1964.
DOI : 10.1146/annurev.me.15.020164.001123

F. Pagès, A. Berger, M. Camus, F. Sanchez-cabo, A. Costes et al., Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer, Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer, pp.2654-66, 2005.
DOI : 10.1056/NEJMoa051424

F. Pagès, A. Kirilovsky, B. Mlecnik, M. Asslaber, M. Tosolini et al., In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, p.106147, 1200.
DOI : 10.1200/JCO.2008.19.6147

G. C. Prendergast, Immunological thought in the mainstream of cancer research: Past divorce, recent remarriage and elective affinities of the future, OncoImmunology, vol.27, issue.6, 2012.
DOI : 10.1038/onc.2008.35

Z. Qin and T. Blankenstein, CD4 + T Cell???Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFN?? Receptor Expression by Nonhematopoietic Cells, Immunity, vol.12, issue.6, pp.677-686, 2000.
DOI : 10.1016/S1074-7613(00)80218-6

C. M. Ribic, J. Daniel, M. J. Sargent, S. N. Moore, A. J. Thibodeau et al., Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer, New England Journal of Medicine, vol.349, issue.3, pp.247-57, 2003.
DOI : 10.1056/NEJMoa022289

R. Røge, R. Riber-hansen, S. Nielsen, and M. Vyberg, Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining, Breast Cancer Research and Treatment, vol.134, issue.Suppl 1, pp.11-19, 2016.
DOI : 10.1111/j.1365-2818.1984.tb02501.x

S. A. Rosenberg, A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens, Immunity, vol.10, issue.3, pp.281-87, 1999.
DOI : 10.1016/S1074-7613(00)80028-X

M. Saqui-salces and J. L. Merchant, Hedgehog signaling and gastrointestinal cancer, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1803, issue.7, 2010.
DOI : 10.1016/j.bbamcr.2010.03.008

R. D. Schreiber, L. J. Old, and M. J. Smyth, Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion, Science, vol.144, issue.5, 2011.
DOI : 10.1016/j.cell.2011.02.013

F. C. Silva, M. Carneiro-da, F. Dominguez-valentin, D. M. De-oliveira-ferreira, . Carraro et al., Mismatch repair genes in Lynch syndrome: a review, Mismatch Repair Genes in Lynch Syndrome: A Review, pp.46-51, 2009.
DOI : 10.1002/bjs.1800840228

C. Sonnenschein, A. M. Et, and . Soto, The Death of the Cancer Cell, Cancer Research, vol.71, issue.13, pp.10-1158, 2011.
DOI : 10.1158/0008-5472.CAN-11-0639

D. L. Stoler, N. Chen, M. Basik, M. S. Kahlenberg, M. A. Rodriguez-bigas et al., The onset and extent of genomic instability in sporadic colorectal tumor progression, Proceedings of the National Academy of Sciences 96, pp.15121-15126, 1999.
DOI : 10.1016/S0092-8674(00)81848-6

O. Stutman, Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice, Science, vol.183, issue.4124, pp.534-570, 1974.
DOI : 10.1126/science.183.4124.534

O. Stutman, « Chemical Carcinogenesis in Nude Mice: Comparison between Nude Mice from Homozygous Matings and Heterozygous Matings and Effect of Age and Carcinogen Dose, Journal of the National Cancer Institute, vol.62, issue.2, pp.353-58, 1979.

J. Taïeb, MSI phenotype and resectable colorectal cancer: clarifying things, La Lettre du Cancérologue, 2011.

M. Terabe and J. A. Berzofsky, Immunoregulatory T cells in tumor immunity, Current Opinion in Immunology, vol.16, issue.2, 2004.
DOI : 10.1016/j.coi.2004.01.010

S. Thies and R. Langer, Tumor Regression Grading of Gastrointestinal Carcinomas after Neoadjuvant Treatment, Frontiers in Oncology, vol.3, 2013.
DOI : 10.3389/fonc.2013.00262

URL : https://doi.org/10.3389/fonc.2013.00262

L. Thomas, On immunosurveillance in human cancer, YaleJ. Biol. Med, vol.55, pp.329-333, 1982.

S. M. Thompson, R. A. Craven, N. J. Nirmalan, P. Harnden, P. J. Selby et al., Impact of pre-analytical factors on the proteomic analysis of formalin-fixed paraffin-embedded tissue, PROTEOMICS - Clinical Applications, vol.118, issue.3-4, 2013.
DOI : 10.1309/URLK-6AVK-331U-0V5P

J. W. Toh, S. H. Paul-de-souza, P. Lim, W. Singh, W. Chua et al., The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy, Clinical Colorectal Cancer, vol.15, issue.4, 2016.
DOI : 10.1016/j.clcc.2016.07.007

E. Vacchelli, L. Galluzzi, A. Eggermont, W. Hervé-fridman, J. Galon et al., Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy, OncoImmunology, vol.62, issue.6, 2012.
DOI : 10.1016/j.jaad.2009.07.004

URL : http://www.tandfonline.com/doi/pdf/10.4161/onci.20931?needAccess=true

E. Vacchelli, I. Martins, A. Eggermont, W. Hervé-fridman, J. Galon et al., Trial watch, OncoImmunology, vol.6, issue.9, 2012.
DOI : 10.1016/j.immuni.2009.09.007

S. Velho, C. Moutinho, L. Cirnes, C. Albuquerque, R. Hamelin et al., BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?, BMC Cancer, vol.51, issue.2, pp.255-265, 2008.
DOI : 10.1136/gut.51.2.200

B. Vogelstein, E. R. Fearon, S. R. Hamilton, S. E. Kern, A. C. Preisinger et al., Genetic Alterations during Colorectal-Tumor Development, Genetic Alterations during Colorectal-Tumor Development, pp.525-3210, 1056.
DOI : 10.1056/NEJM198809013190901

I. Waldhauer, A. Et, and . Steinle, NK cells and cancer immunosurveillance, Oncogene, vol.178, issue.45, 2008.
DOI : 10.1038/nri1936

URL : http://www.nature.com/onc/journal/v27/n45/pdf/onc2008267a.pdf

Y. Wang, Q. Peng, H. Jia, and X. Du, Prognostic value of hedgehog signaling pathway in digestive system cancers: A systematic review and meta-analysis, Cancer Biomarkers, vol.16, issue.1, pp.71-79, 2016.
DOI : 10.3233/CBM-150542

G. Willimsky and T. Blankenstein, Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance, Nature, vol.158, issue.7055, 2005.
DOI : 10.1089/hum.1997.8.14-1695

K. Yasuda, T. Nirei, E. Sunami, H. Nagawa, and J. Kitayama, Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer, Radiation Oncology, vol.6, issue.1, pp.6-49, 2011.
DOI : 10.1038/nm1622

L. Zhang, « Immunohistochemistry versus Microsatellite Instability Testing for Screening Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome. Part II. The Utility of Microsatellite Instability Testing, The Journal of Molecular Diagnostics: JMD, vol.10, issue.4, 2008.

F. Zhong, R. Bi, B. Yu, F. Yang, W. Yang et al., A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer, PLOS ONE, vol.22, issue.8, 2016.
DOI : 10.1371/journal.pone.0150505.s001

L. Zitvogel, L. Apetoh, F. Ghiringhelli, and G. Kroemer, Immunological aspects of cancer chemotherapy, Nature Reviews Immunology, vol.313, issue.1, pp.10-1038, 2008.
DOI : 10.4049/jimmunol.172.4.2039

É. Pratique, D. Hautes, . Etudes, . De, . Vie et al., Exploration de la composante immunitaire des cancers colorectaux par des approches d'imagerie et transcriptomiques. Implications cliniques potentielles Marliot Florence Date de soutenance, pp.24-2017

. Le-rôle-de-la-réaction-immunitaire and . Au, hui reconnu comme étant déterminant dans l'évolution clinique des patients présentant un cancer Dans les cancers colorectaux, nous avons observé un impact pronostique majeur de l'infiltration immunitaire. Une forte infiltration en lymphocytes TCD3+ et TCD8+ cytotoxiques dans un contexte d'orientation

». Immunoscore and . Sur-une-technique, Des performances intrinsèques de ce test en termes de robustesse, de répétabilité et de reproductibilité ont été analysées pour valider ce test en pratique clinique. Pour valider et promouvoir l'Immunoscore comme un nouveau paramètre de la classification du cancer en routine clinique, un consortium international a été initié. Les résultats obtenus de cette étude internationale montrent que l